Table 2.
Results of multiple logistic regression analysis for unfavourable (mRS ≥2) and poor (mRS ≥3) outcome in all patients and four subgroups
| All patients | BZ group | ML group | LT group | SL group | ||||||
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Model 1, mRS ≥2 | ||||||||||
| FVH (+) | 3.02 (1.49 to 6.13) | 0.002 | 4.22 (1.25 to 14.25) | 0.021 | 5.44 (1.41 to 20.92) | 0.014 | 1.95 (0.24 to 15.90) | 0.531 | 0.24 (0.01 to 7.36) | 0.410 |
| Male | 2.00 (0.86 to 4.66) | 0.110 | 0.20 (0.02 to 2.12) | 0.180 | 0.91 (0.17 to 4.99) | 0.911 | 8.74 (0.31 to 246.91) | 0.203 | 3.55 (0.49 to 25.78) | 0.211 |
| Age | 1.00 (0.97 to 1.03) | 0.870 | 1.01 (0.96 to 1.08) | 0.654 | 1.02 (0.96 to 1.09) | 0.448 | 0.97 (0.89 to 1.06) | 0.499 | 1.01 (0.93 to 1.11) | 0.761 |
| Occlusion | 1.67 (0.77 to 3.59) | 0.192 | 1.14 (0.97 to 1.33) | 0.103 | 0.58 (0.15 to 2.18) | 0.420 | 20.51 (1.69 to 248.68) | 0.018 | 1.08 (0.03 to 33.89) | 0.965 |
| NIHSS-ad | 1.18 (1.09 to 1.28) | <0.001 | 14.19 (1.40 to 143.85) | 0.025 | 1.24 (1.06 to 1.46) | 0.007 | 1.24 (0.96 to 1.60) | 0.093 | 1.03 (0.72 to 1.46) | 0.882 |
| Model 2, mRS ≥3 | ||||||||||
| FVH (+) | 2.25 (1.01 to 4.97) | 0.046 | 5.52 (0.98 to 31.07) | 0.053 | 4.09 (1.04 to 16.16) | 0.045 | 1.53 (0.16 to 14.40) | 0.709 | NA | NA |
| Male | 1.40 (0.54 to 3.62) | 0.488 | 0.30 (0.02 to 3.94) | 0.363 | 0.56 (0.09 to 3.58) | 0.537 | 8.48 (0.33 to 217.26) | 0.197 | 0.70 (0.08 to 6.26) | 0.754 |
| Age | 1.00 (0.97 to 1.03) | 0.937 | 1.05 (0.96 to 1.14) | 0.338 | 1.03 (0.97 to 1.09) | 0.318 | 0.88 (0.77 to 1.00) | 0.051 | 1.04 (0.93 to 1.16) | 0.511 |
| Occlusion | 2.90 (1.32 to 6.37) | 0.008 | 32.43 (3.21 to 327.27) | 0.003 | 2.10 (0.57 to 7.82) | 0.268 | 5.39 (0.54 to 54.04) | 0.152 | 0.01 (0.01 to 999.99) | 0.999 |
| NIHSS-ad | 1.21 (1.11 to 1.31) | <0.001 | 1.34 (1.07 to 1.68) | 0.010 | 1.14 (1.02 to 1.27) | 0.019 | 1.69 (1.18 to 2.44) | 0.004 | 1.30 (0.83 to 2.02) | 0.253 |
Model 1 used mRS ≥2 as dependent variable; model 2 used mRS ≥3 as dependent variable.
The bolded entries mean significance.
BZ group, border-zone infarct group; FVH, fluid-attenuated inversion recovery vascular hyperintensity; LT group, large territory infarct group; ML group, multiple lesion infarcts group; mRS, modified Rankin Scale; NA, not available; NIHSS-ad, National Institute of Healthy Stroke Scale at admission; SL group, single cortical or subcortical lesion group.